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Signal processingBackground: The web-based systems available for multi-centre clinical trials do not combine clinical data
collection (Electronic Health Records, EHRs) with signal processing storage and analysis tools. However,
in pathophysiological research, the correlation between clinical data and signals is crucial for uncovering
the underlying neurophysiological mechanisms. A speciﬁc example is the investigation of the mecha-
nisms of action for Deep Brain Stimulation (DBS) used for Parkinson’s Disease (PD); the neurosignals
recorded from the DBS target structure and clinical data must be investigated.
Objective: The aim of this study is the development and testing of a new system dedicated to a multi-
centre study of Parkinson’s Disease that integrates biosignal analysis tools and data collection in a shared
and secure environment.
Methods: We designed a web-based platform (WebBioBank) for managing the clinical data and biosignals
of PD patients treated with DBS in different clinical research centres. Homogeneous data collection was
ensured in the different centres (Operative Units, OUs). The anonymity of the data was preserved using
unique identiﬁers associated with patients (ID BAC). The patients’ personal details and their equivalent ID
BACs were archived inside the corresponding OU and were not uploaded on the web-based platform;
data sharing occurred using the ID BACs. The system allowed researchers to upload different signal
processing functions (in a .dll extension) onto the web-based platform and to combine them to deﬁne
dedicated algorithms.
Results: Four clinical research centres used WebBioBank for 1 year. The clinical data from 58 patients
treated using DBS were managed, and 186 biosignals were uploaded and classiﬁed into 4 categories based
on the treatment (pharmacological and/or electrical). The user’s satisfaction mean score exceeded the
satisfaction threshold.
Conclusions: WebBioBank enabled anonymous data sharing for a clinical study conducted at multiple
centres and demonstrated the capabilities of the signal processing chain conﬁguration as well as its
effectiveness and efﬁciency for integrating the neurophysiological results with clinical data in multi-
centre studies, which will allow the future collection of homogeneous data in large cohorts of patients.
 2014 Elsevier Inc. All rights reserved.1. Introduction
Over the last decade, web-based systems for data collection
have demonstrated their efﬁcacy at supporting and optimising
the management of large-scale multi-centre clinical trials [1–10].
These systems deﬁned and shared dedicated clinical forms reﬂect-
ing the aims of the data collection during the clinical trial, which
were to collecting multi-centric data. During and after the trial,
data analysis is usually performed in single specialised centres,
and only raw data databases remain available for further
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research, the correlation between clinical data and neurophysio-
logical results is crucial to uncover underlying mechanisms.
The investigation of the mechanism of action for using Deep
Brain Stimulation (DBS) against movement disorders, especially
Parkinson’s Disease (PD), is an example. In fact, while DBS is an
established surgical treatment for PD that has recently been intro-
duced to treat other neurological and neuropsychiatric diseases, its
mechanisms of action remain unclear [11–17]. DBS treatment con-
sists of delivering a high frequency electrical stimulus (100–
180 Hz, 60–120 us pulse width, 1–5 V amplitude) through
multi-electrode intracranial catheters to the deep brain structures
targeted based on the pathology treated. The target for PD is the
subthalamic nucleus (STN). Stereotactical neurosurgical proce-
dures allow the precise placement of DBS electrodes in the target
structure. Intraoperative monitoring procedures, including biopo-
tential recordings with high impedance electrodes and functional
stimulation, help to position the electrodes. In a second surgical
procedure, the two electrodes are connected with an electrical
pulse generator placed under the skin near the right shoulder.
The study of the DBS mechanism of action was boosted by the
observation that DBS electrodes, once placed at the target, enabled
the pathophysiology of the target structure to be studied directly
in vivo, particularly the STN and the other basal ganglia structures
for PD [18,19]. Deep electroencephalographic signals, which are
known as Local Field Potentials (LFPs) were recorded and analysed,
providing new insights into the basal ganglia motor and non-motor
functions in PD and other movement disorders as well as the
mechanism of action for DBS [19]. However, until recently, the
research on LFP recorded during DBS was carried out in individual
research centres using heterogeneous experimental protocols,
recording settings, and analysis algorithms. This fragmented situa-
tion produced results that although signiﬁcant, must still be com-
pared and examined together to obtain any relevant and shared
advances. Investigating the mechanisms of action for DBS would
therefore require a coordinated effort between all of the DBS cen-
tres. However because the study of LFP recorded in DBS patients is
an informative tool used to reveal the pathophysiology of PD,
multi-centre clinical trials should combine the data from clinical
assessments with that from the neurophysiological recordings.
Currently, different web-based systems are aimed at facilitating
multi-centre data sharing for clinical trials or combining clinical
data collection with data management and analytics workﬂow,
integrating heterogeneous data and managing external semantic
interoperability, particularly in the genomic/biological ﬁelds
[1–10,20–24].
For example, BTM-Research™ by Daedalus Software [20] allows
the collection, storage, annotation, and tracking of biosamples
across research centres, which allows the sharing of the collection
and research workﬂows. This system is devoted to biological and
genomic data, but it does not allow online signal processing using
shared algorithms or analysis chains. REDCap [22] is a secure web
system for data capture and export in research studies, but does
not include the possibility to create personal analysis functions.
The caBIG experience (now retired by the US National Institutes
of Health, NIH, https://cabig.nci.nih.gov/) provided an open-source
community for cancer data sharing and management, but it did not
provide any tools to create clinical report forms (CRFs) for multi-
centre clinical trials [6]. Similarly, the ‘‘informatics for integrating
biology and the bedside’’ project (i2b2) [7–9] was funded to inte-
grate clinical and research data. To do so, the i2b2 ‘‘hive’’ provides
a set of software modules called ‘‘cells’’ based on a common mes-
saging protocol with interactions through web services and XML
messages. The cells are developed by single researchers before
integration into the hive, providing a scalable approach for the
genomic research area. All of the software services are developedto contribute to the Clinical Research Chart (CRC). The CRC is fed
by messages in form of an XML schema containing a header for
the deﬁnition of basic communication information as well as a
body with patient sets, including their phenotypic and genotypic
data. However i2b2 does not support the creation of CRF for clinical
trials. Other examples such as LORIS [5], OnWARD [10] are web-
based tools for multicentre shared data management and scientiﬁc
collaboration that are also ontology-based [10] but do not allow
the management of signals and signal processing algorithms/
chains. The SciPort system [25] is a web-based platform for scien-
tiﬁc collaboration, integrating and sharing data from distributed
institutions. It provides an XML based general approach to model
complex scientiﬁc data by representing them as XML documents
and allows each institution to manage documents independently
on a Local SciPort Server.
However, none of the available examples integrated the neuro-
physiological signals with the collection of clinical data in a frame-
work that provided a web-based multicentre-shared environment
while allowing for a standard-based interoperable electronic
health record EHR and the direct creation of CRFs for supporting
multicentre clinical trials.
In this study, we describe the design, implementation and pre-
liminary use of a new platform: WebBioBank. This platform has
been developed speciﬁcally for combining the management and
sharing of DBS patient EHR and biosignals (LFPs), including shared
algorithms for DBS biosignal analysis, that were recorded during
deﬁnable protocols as well as allowing for the possibility to create
CRFs. The system may be accessed through a standard web brow-
ser, allowing users to perform various tasks for data management
in an anonymous mode according to shared protocols. This system
represents a new tool for the real time interaction between
researchers and clinicians in different DBS centres. The clinicians
will be able to add and manage information regarding a patient’s
history, neurological signs and symptoms, therapy, neuropsycho-
logical test and scales, DBS surgery and follow-up. The researchers
will provide shared advanced algorithms for LFP signal processing
that can be combined in analysis chains, ensuring that the extrac-
tion of the LFP features is the same in all of the centres involved in
the research study. The available analysis algorithms can be
applied to the raw data to extract signiﬁcant LFP features that
can be correlated to the patient’s clinical state, as reported in the
literature. Moreover, the system is open to any additional algo-
rithm uploaded by researchers and can share it among centres.
The system also ensures the anonymity of the clinical data/biosig-
nal collection, protecting the privacy of the patients during large
studies by other clinical centres. Since WebBioBank integrates
the functionalities of traditional EHRs with those of research sup-
port systems, such as clinical research management systems
(CRMS), it implements a ‘‘research’’ EHR (rEHR).
In the ﬁrst part of the paper, we describe the technical aspects
of this new system (requirements, architecture, prototype, data
type and processing, UML use case and activity diagrams). In the
second part of the paper, we present the results from the ﬁrst
implementation of the prototype in a DBS multi-centre study,
showing its capability in a research ﬁeld in which these technical
aspects are highly required. Finally, we highlight the limitations
and innovative aspects of the new system from its ﬁrst implemen-
tation while comparing it to an existing system.2. Material and methods
2.1. Requirements
WebBioBank was designed to meet the following requirements:
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shared between different centres will guarantee the availability
of comparable data to clinicians, researchers, and biosignal
analysis specialists, while signals and data should be locatable,
supporting a faster and more cost-effective protocol.
2. The integrated management of clinical data and biosignals will
help to study the correlations between the clinical data and
neurophysiological results to uncover the underlying
mechanisms.
3. Uploading the mathematical and statistical shared algorithms
that can be combined on-line to create signal processing chains
speciﬁcally dedicated to LFP analysis will provide a set of tools
to biosignal analysis experts ensuring that biosignal analysis is
performed uniformly between centres and that the neurophysi-
ological results are comparable.
4. Anonymous data processing and sharing between different cen-
tres ensuring patient’s privacy also when involved in multi-cen-
tre studies.
5. Users with different roles (Role-Based Access Control) will gain
access according to their job function [26] in the clinical centre
during each speciﬁc research protocol. User access must be con-
trolled using authentication to avoid unauthorised access. Each
user will only be authorised for access to the web-applications
that implement their corresponding job tasks according to their
assigned role.
6. The customisable database according to the research protocol
applied for faster query performance during data extraction will
facilitate data re-use from both the clinical and the neurophysi-
ological viewpoints.
7. The possibility to create ad-hoc Clinical Report Forms (CRFs)
dedicated to multi-centre clinical studies using shared
templates will support researchers involved in clinical trials
requiring speciﬁc data collection compliant with available
regulations.
8. Compliance with rules and requirements to allow its use in a
clinical setting is required because increasing amounts of data
are captured digitally during clinical routine care; making these
data available for scientiﬁc research has been discussed exten-
sively [26].
2.2. Content and technology of the web-based system prototype
wHospital is a proprietary conﬁgurable framework (Laser
Biomed SpA) for the hospital EHR management which is currently
used in many Italian and European hospitals. We conﬁgured and
expanded the wHospital basic framework by adding newly devel-
oped functionalities to support multicenter clinical studies (such
as the de-identiﬁcation of patients) as well as a new module for
biosignal storage, management, and analysis (processing layer).
WebBioBank is hence a new system completely separated from
wHospital that allows managing heterogeneous data in an anony-
mous way during multicenter studies that include also biosignal
analysis and collection that we deﬁned rEHR.
The framework deﬁnes a two-level user architecture: at the ﬁrst
level, there is the single clinical centre (named Operative Unit, OU),
while a network of OUs called the ‘‘Super Operative Unit’’ (sOU) is
available at the second level. The sOU is created and managed by
the system administrator. The access policies are based on the def-
inition of user roles. Each user is associated with a role that deﬁnes
his/her the rights on data views and functions. The pre-deﬁned
user roles include the administrator, clinician, nurse and pharma-
cist. The system administrator can deﬁne additional roles accord-
ing to the needs of the clinical centre or study.
The sOU administrator can conﬁgure a unique rEHR template
working in all of the OUs included in the sOU. This allows homoge-neous patient data collection and sharing among OUs belonging to
the same sOU.
Each OU administrator can deﬁne the speciﬁc OU rEHR tem-
plate, which is composed of modules (the Clinical Forms) that will
be automatically translated into relational database tables accord-
ing to the type of data collected. Any OU rEHR can be shared with
other OUs included in the same sOU. Patients belonging to a single
OU cannot be viewed by another OU unless speciﬁcally authorised.
Consequently, homogeneous data collection is possible when shar-
ing a deﬁned OU rEHR among different OUs belonging to the same
OU.
The ﬁelds in each clinical form are mapped onto an ontology of
‘‘clinical concepts’’ that allow the exchange of information among
OUs using different forms, but with the same semantics. The ‘‘clin-
ical concepts’’ act as mediators between heterogeneous data
sources, which may conﬂict due to their structure or context. The
‘‘clinical concepts’’ can be used to label each ﬁeld of a Clinical Form
and, acting as metadata, to make the semantic content of the ﬁeld
explicit for further use. For example, the ‘‘clinical concepts’’ can be
used to extract information from the patient’s rEHR and feed a
form dedicated to a speciﬁc data collection for a clinical trial. This
is particularly useful when a single OU participates to more clinical
trials that may require semantically equal information collected on
syntactically different forms.
Additionally, when conﬁguring a speciﬁc rEHR template, the
administrator can deﬁne a terminology to facilitate homogeneous
data collection. This function is called the ‘‘Dictionary’’, and it can
be deﬁned either using standard terminologies, such as SNOMED
CT, or using ad-hoc terminologies deﬁned by consensus and speciﬁc
for the study. After conﬁguring the dictionary, it is necessary to asso-
ciate it with a MultiLineTextBox control in the Clinical Form to help
the clinicians during information gathering. The ‘‘Dictionary’’ can be
shared among the OUs included in the same sOU, ensuring that data
collected in different OUs use the same semantics.
To enable anonymous data collection, the WebBioBank saves
the patient’s registry (external ﬁle with .xml format) and its corre-
sponding identiﬁer code (ID BAC) locally in the single OU informa-
tion system; on the web-based platform, only the unique ID BAC of
patients are saved and there are no records composed by both data
and codes corresponding to obscured personally identiﬁable infor-
mation. Records composed by patient’s personal information and
ID BAC are stored only in a local registry ﬁle (composed by identi-
ﬁers and ID BAC) managed only by the authorized user during data
collection: identiﬁers are not loaded into the web-based platform
but they are necessary to insert data and signal in the correspond-
ing rEHR. In WebBioBank there are only records composed by ID
BAC and neurological parameters stored, and the ID BAC is the
identiﬁcation number of the single record.
These ID BACs can be transferred to other OUs. Therefore, the
system can be ﬂexibly adapted to manage single-and multi-centre
data and signal collection. In a single-centre data collection, a
research centre is deﬁned as an OU and can deﬁne rEHR and exper-
imental protocols for data collection. In the multi-centre data col-
lection, each participating centre is an OU, and the OUs are
grouped in a sOU. Within the sOU, users can share data based on
a common rEHR template deﬁned for the speciﬁc multi-centre
study. The system can also support the creation of CRFs for clinical
trials: a CRF can be deﬁned as a Clinical Form belonging to a
patient’s rEHR, and the clinical concepts needed for feeding the
CRF can be extracted from the rEHR, facilitating data collection.
More speciﬁcally, the creation of CRF is allowed according to the
standard HL7 Clinical Document Architecture, R2 (CDAR2). During
the generation of CRFs, data are encoded according to a common
code system. In fact, CDAR2 codiﬁcation allows data coming from
several projects to be built using common metadata and to be
structured using a consistent data model.
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the present prototype: a speciﬁc role for the data management
and signal processing inside the sOU. A user with this new role
can view all of the data and signals of the multi-centre clinical
study information with only the corresponding ID BAC. The Data
Manager is created by the sOU administrator and can be either
associated with an existing OU or an independent user role.
In a multi-centre DBS study, each OU represents a single DBS
centre and has different user roles. The OU Administrator role
can create the OU and give the password to other users (clinicians
or researchers). Each user belongs to an OU and can access the OU
list of patients, create new patients, view or ﬁll out clinical data
forms associated with the OU. A single OU may be associated with
one or more multi-centre studies (sOU). Usually, the Data Manager
can access anonymous data from all of the OUs and analyse them
with a shared analysis protocol; this user is associated with the
research centre devoted to data analysis.
Fig. 1 summarises the general process for data management as
well as the roles for the different users. The users are classiﬁed into
three roles according to their tasks: Administrator, User and Data
Manager. Each OU has an administrator and at least two users (cli-
nician and researcher) who insert data. The Administrator of the
sOU can give a single OU access to the multi-centre study and con-
ﬁgure the clinical data form according to the protocol of the study.
The Data Manager can view and process all of the data collected by
the different centres.
2.3. System architecture
WebBioBank is based on a three-layered architecture: a web
application layer, a processing layer and an infrastructure layer
(Fig. 2A). In summary, the web-application layer allows the conﬁg-
uration of a unique common template for data sharing in multi-
centre studies. The processing layer satisﬁes the research needs
and allows for conﬁguring processing chains that are dedicated
to biosignal analysis. The infrastructure layer implements patient’s
privacy, user’s authentication, the customisable database and the
rules to enable use in a clinical setting. The second layer wasFig. 1. WebBioBank general processspeciﬁcally developed for WebBioBank and it is not available in
wHospital that includes only the web-application and the infra-
structure layers.
The web-application layer is designed in ASP.NET, Silverlight
and C# languages; it consists of applications (modules, Fig. 2A) that
manage patient’s records (rEHRs) patient’s registries, and signal
processing interface. The rEHR modules can be ‘‘vertical’’ if it fully
works within a certain rEHR in a certain OU (for example, patient’s
medical history or therapies) or ‘‘horizontal’’ if it does not belong to
a single rEHR (for example, patients’ lists, or the experimental pro-
tocol for signal acquisition).
The processing layer consists of server side service operations
that extract the original signals and metadata (previously uploaded
by users in .txt format) from the database and elaborate them
according to the speciﬁc processing chain, as requested by the user.
The resulting signals and metadata are stored in the same database
located on the server. Any other processing is performed remotely.
In WebBioBank, many processing chains can be created for differ-
ent research protocols: users can upload mathematical and statis-
tical algorithms (.dll extension) to create single analysis blocks that
can be combined in appropriate sequences by researchers, creating
dedicated processing chains. The collection of the mathematical
and statistical algorithms (as a .dll extension) in the processing
layer is not a pre-existing library implemented by the system
developers; the library is built through the work of users/research-
ers in the ﬁeld (Fig. 2B).
The infrastructure layer is provided by the wHospital frame-
work [27], which uses a relational database management system
(RDBMS); the data are stored in a subject-centric manner and are
accessible via the web. The server database is managed with a
Microsoft SQL Server 2008 R2, but the wHospital framework allows
the administrators to access and conﬁgure the database (for exam-
ple, create new tables, j-query, data views) through a dedicated
web-page called the ‘‘Framework Manager’’. The access to the
Framework Manager is strictly regulated to prevent unauthorised
database access.
Fig. 2C shows the Entity Relationship (ER) model of WebBio-
Bank database. In a multi-centre view, the entity ‘‘OU’’ (Operativefor a DBS multi-centre study.
Fig. 2a. WebBioBank architecture.
Fig. 2b. WebBioBank handshake sequence diagram.
96 E. Rossi et al. / Journal of Biomedical Informatics 52 (2014) 92–104Unit) represents the single clinical centre using the system, and the
‘‘SuperOU’’ (super Operative Unit) represents an aggregation of
OUs that share information, templates for data collection, and an
analysis algorithm, similar to a clinical trial. Each OU can deﬁne
a speciﬁc rEHR (entity ‘‘rEhrDef’’) composed of modules (‘‘Module-
Def’’) called Clinical Forms. The structure of each Clinical Form is
conﬁgurable, and the ﬁelds chosen in a Clinical Form create a
Direct Table in the database (entity ‘‘DTModuleDeﬁnition’’). To
ensure semantic interoperability, each ﬁeld in the Clinical Forms
is connected to a clinical concept included in a ‘‘Dictionary’’, guar-
anteeing information exchange even if the syntax used among OUs
differs. Users and their roles are deﬁned for each OU according to
the internal access rules. The processing algorithms (‘‘Processing
DLL’’) are the biosignal analysis modules. Each patient has an
‘‘rEHR’’ connected to his/her ‘‘SignalDataSet’’. In the database
architecture, signals resulting from the processing algorithms are
stored as ‘‘children’’ of the raw signals uploaded, inheriting the
characterising properties and metadata of the raw signals.This overall database architecture allows the sOU administrator
to deﬁne a unique Clinical Form template according to the com-
mon research protocol during multi-centre studies. Additionally,
the entities ‘‘rEHR’’ and ‘‘SignalDataSet’’ are characterised by the
rEHR conﬁguration of the equivalent OU and include the patient’s
value.
2.4. Signal type and processing at different levels
The signal upload is usually occurs in the .txt format because
the LFP recordings are generally stored according to the EDF
(European Data Format) standard, and any biosignal acquisition
system allows the export of raw data in .txt format. Each signal
is characterised by its main acquisition parameters (sampling rate,
bandwidth, number of channels recorded, ADC rate, recording sys-
tem, gain); it is associated with a speciﬁc event/experiment that
describes the experimental recording setting (i.e., patient with
DBS implant, during a motor task, with DBS turned off). The
Fig. 2c. WebBioBank ER model.
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forms part of the rEHR deﬁned for the speciﬁc multi-centre study
protocol. In addition, the association between the signal and the
patient rEHR through the ID BAC ensures that all of the clinical data
available regarding the patient can be considered when interpret-
ing the results.
In general, the acquisition parameters are pre-deﬁned in the
experimental protocol to ensure comparable analysis results in
each multi-centre clinical study. However, the metadata associated
with the single signal provides sufﬁcient details for signal re-use
when combined with the details of the experimental protocol to
which the acquisition belongs.
While deﬁning the multi-centre study protocols during the con-
ﬁguration of the sOU, the Data Manager usually determines the LFP
acquisition parameters and prepares the shared acquisition form
for use during the study, according to the experimental setting.
The researchers of the different OUs will upload raw data ﬁles
and check the acquisition parameters for the dedicated form.
Subsequently, in WebBioBank, the signal processing can be per-
formed both at the OU and the sOU level. The signal processing at
the single OU level involves the roles of the researcher:
They can collect and process biosignals recorded through the
DBS electrodes (upload, classify, display and create dedicated sig-
nal processing chains). A dedicated module for signal processing
is included in each OU: researchers can upload the signal in .txt
format, including the metadata (sampling rate, bandwidth, number
of channels recorded, ADC rate, recording system, gain). The signalcan be then displayed with a ‘‘Biosignal Viewer’’ and processed. In
the module for signal processing, a processing chain can be deﬁned
by combining different mathematical and statistical functions (in
.dll format). Algorithms can be created in Matlab and compiled
to obtain the .dll for upload, creating an analysis block. The
researcher can use either personally uploaded or the available
shared algorithms/chains. Signals are all processed remotely by
the central server.
Conversely, at the sOU level, the signals are processed by the
Data Manager. The signals collected from each OU are remotely
processed according to the common algorithms deﬁned for the
analysis in a multi-centre study. All of the signals collected by all
of the OUs in the study can be processed and compared.
In both cases, the signals are processed remotely. For the data
exchanged between the analysis blocks, each .dll algorithm pro-
cesses signals with a predeﬁned dimension and format: a 2  N
matrix in .txt format. The output of each analysis is in the same
2  N format. A parent–child relationship between the raw and
processed signals ensures that the analysis results inherit all of
the metadata related to the experiment during which the signal
was acquired.
2.5. Using WebBioBank
The WebBioBank actors include the following: the administra-
tor of sOU, the data manager and a single operative user (clinician,
researcher or administrator of the operative unit). The sOU
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centres research protocol. This use case includes the systematic
addition of different operative units (research centres) that partic-
ipate in the protocol and the creation of an account for the Data
Manager. The ‘‘System Conﬁguration’’ use case deﬁnes the type
of measures, signal classiﬁcation, database architecture, type and
roles of users, section andmodules of the clinical forms. All of these
deﬁnitions depend on the speciﬁc research protocol and are
deﬁned by the sOU administrator and the Data Manager. The Sys-
tem Conﬁguration includes the creation of user accounts for each
operative unit. The OU user can add new patients (new registry
item and new clinical forms associated to the patient) and analyse
data regarding only his/her patients. The personal details of
patients are managed locally: the Data Manager can only elaborate
the anonymous data collection.2.6. Multi-centre study workﬂow
Before WebBioBank is used for a new multi-centre study, the
administrator of the sOU must perform the following tasks (Fig. 3):Fig. 3. Multi-centre study workﬂow using1. Deﬁne the protocol of the trial (type of data, content of clinical
forms, signal processing algorithms) in collaboration with all of
the professionals involved in the study to standardise the data
collection.
2. Create the sOU, including the OUs representing each research
centre involved, and give the Data Manager the password to
access to the sOU and access to all anonymous data collected
from all of the clinical centres.
3. Conﬁgure the system and the database according to the proto-
col in collaboration with the Data Manager and check the con-
ﬁguration according to the research protocol.
4. Give the password to single OUs for their administrator and
users (clinicians and researcher).
Consequently, each OU from the sOU will have the same clinical
form template, signal processing application and user’s roles
according to the protocol deﬁned. All of the data will be automat-
ically sent to the sOU without any personal information to ensure
anonymous data sharing. Once the system is conﬁgured, data col-
lection can begin: inside the single OU, users can insert clinical
data and bio-signals through a user-friendly interface:WebBioBank (UML activity diagram).
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or hospitalisation for surgery.
 Researchers can upload, classify, and preprocess biosignals
(particularly LFPs).
During data collection, the OU users can extract data regarding
the OU patients in Excel format. The Excel ﬁle will not include reg-
istry data from patients; only the patient ID BAC will be utilised.
This ﬁle could be useful for local periodic monitoring.
At the end of data collection, the Data Manager of the sOU will
be able to manage all data collected from the different OUs.3. Results
3.1. WebBioBank implementation
Users can access WebBioBank through three sections of its
front-end layer: (1) Patient List (Fig. 4A), (2) Clinical Form
(Fig. 4B), and (3) Signal Processing Module (Figs. 4C and 4D).
Fig. 4A shows the user interface for clinicians within a single
OU: the user can create a new patient and export the personal
information of the OU patient in a .xml ﬁle. Consequently, only
the ID BAC is shared on the network, ensuring anonymity during
data processing. Fig. 4B shows an example of a clinical form that
all of the clinicians of each OU can ﬁll in during the visits, enabling
homogeneous data collection within the same sOU. The template
for the clinical form is deﬁned by the administrator of the sOU; this
person can create the OU within the sOU, insert the users’
accounts, assign their roles, deﬁne the clinical form template, and
create relative database tables.
Concurrently, the researchers can access the signal processing
module (Figs. 4C and 4D) to manage the biosignals. In this module,
the signals can be uploaded, classiﬁed, and viewed and the chains
of processing algorithms can be deﬁned. In the case of a multi-Fig. 4a. Patient identiﬁers on the web-based platform and the personacentre study, a set of signal processing chains has to be deﬁned
and shared inside the sOU.3.2. Present use results
A ﬁrst release of WebBioBank was used over the last year for a
multi-centre study of DBS patient, named ‘‘Local ﬁeld potential
recordings in Parkinson’s Disease from deep basal ganglia struc-
tures during levodopa and DBS therapy: a multi-centre Italian
stud’’.
The study comprised 4 DBS research centres in the Lombardy
Region: the Fondazione IRCCS Ca’ Granda Ospedale Maggiore Poli-
clinico (Milan), the IRCCS Galeazzi (Milan), the IRCCS Istituto Naz-
ionale Neurologico Carlo Besta (Milan), and the IRCCS Istituto
Neurologico Mondino (Pavia). The study aimed to establish the
effect of levodopa and DBS on the LFP oscillatory pattern in PD to
understand whether the pharmacological and the electrical thera-
pies share a similar mechanism of action. Moreover, this prelimin-
ary study deﬁned the LFP-based variable for future adaptive DBS
therapies [18,19,28].
The PD patients were enrolled according to the standard criteria
for DBS [29]; they signed written informed consent forms saved on
WebBiobank. The study was performed according to the Declara-
tion of Helsinki and was approved by local ethical committees.
Patients were assessed during a visit before undergoing DBS;
afterward, they underwent surgery for DBS electrode placement.
The electrodes were placed primarily in the STN, but some case
studies involved electrodes placed in the Globus Pallidus internus
(GPi) and in the Pedunculopontine Nucleus (PPN). Two or three
days after surgery, when the electrode wires were still accessible
before the connection to the high-frequency pulse generator, LFPs
were bilaterally recorded in the following conditions: ON pharma-
cological treatment, ON DBS treatment, without treatment, or ON
DBS-ON pharmacological treatment. Not all patients were recorded
under all conditions based on their clinical state. However, thel information exported by the clinician in the local environment.
Fig. 4b. Clinical Form conﬁgured according to the common study protocol.
Fig. 4c. Biosignal viewer.
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same between centres.
Recordings during DBS were performed using the FilterDBS sys-
tem, allowing simultaneous LFP recordings while DBS is turned ON
from the same electrode [30].
Ad-hoc clinical forms were deﬁned to manage the clinical data
collections involvingmore than 10 clinicians. According to the pres-
ent DBS multi-centre protocol, the sOU Administrator conﬁgured
rEHRwith the following structure: each rEHR includes two sessionsnamed ‘‘Clinical Data’’ and ‘‘Evaluation Scales’’. The ﬁrst includes
the following clinical forms: PD onset (Table 1) pre-DBS surgery
visit, DBS surgery details, follow-up visit and cause of death. The
‘‘Evaluation Scales’’ section is composed of the Uniﬁed Parkinson
Disease Rating Scale (UPDRS) Parts I, II, III and IV evaluated before
and after DBS surgery. When the rEHR was conﬁgured by the sOU
Administrator, the framework automatically generates an empty
table in the SQL database for each clinical form. These tables than
are populated by clinicians during the patient evaluations.
Fig. 4d. Signal processing module used for deﬁning a processing chain.
Table 1
Data type collected in the ‘‘PD onset’’ clinical form.
Data name Data type User web interface
Gender string Radio button list
Education number Single line text box
Motor symptoms string Checkbox list
Side onset string Checkbox list
Side onset string Checkbox list
Neuropsychiatric symptoms string Checkbox list
Autonomic symptoms string Checkbox list
Sleep disorders string Checkbox list
Onset data data Date time
Genetics string Multiline text box
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neous terminology for PD description, in order to compare patients
evaluated by different clinicians in the different centres. To do so,
after having reached a consensus among the clinicians involved
in the study, the function ‘‘Dictionary’’ allowed the creation of a
shared terminology for the description of: (1) the causes and con-
sequences of patient’s falls; (2) the causes of hospitalization after
DBS implant; (3) the patient’s drug therapy, including antidepres-
sant, psychotic, and dementia drugs. This terminology was linked
to the dedicated rEHR ﬁelds, so that the clinicians could choose
among the shared terms without using free text. Conversely, in this
multicentre study, it was not necessary to implement the ‘‘Clinical
Concepts’’ because all the forms were shared and speciﬁcally con-
ﬁgured for the trial and none of the clinical centre required addi-
tional un-shared forms.
For the data extraction, speciﬁc views on the SQL database were
generated by the Data Manager to collect data from all of the DBS
research centres into a single and easy-to-use excel ﬁle. These
views include both the clinical data and the signal elaboration
outputs.The researchers uploaded approximately 186 LFPs recorded
from the STN, GPi, and PPN; this dataset represents the largest
homogenous collection of DBS LFP recordings in PD patients
(Table 2). The signals were analysed using the ad-hoc functions
uploaded in WebBiobank. To evaluate the oscillatory nature of
the LFPs, signals were studied in the time domain and in the fre-
quency domain after pre-processing. LFPs were studied in the clas-
sical EEG frequency range (below 50 Hz). In particular, the
low-frequency (2–7 Hz), low-beta (10–20 Hz), high-beta (20–35 Hz),
and gamma (35–45 Hz) were studied. Table 3 shows the list of
functions used for spectral analysis and noise reduction generated
by the Data Manager: each function represents an analysis block
and is concatenated into the processing chain dedicated for the
present multi-centre DBS study. The ‘‘Rimozione_DC’’ was the ﬁrst
analysis block of the processing chain, and it was used to remove
the DC component from the raw signal uploaded by the clinical
centre. Then, the researcher could choose between different analy-
sis blocks in order to perform a signal analysis in time or frequency
domain. For example, the ‘‘Filtraggio_banda_Alfa’’ block can be
applied to ﬁlter the pre-processing signal in the band 8–12 Hz
through a band pass ﬁnite impulse response (FIR) ﬁlter. Another
possibility was to apply the ‘‘Spettro’’ block to calculate the power
spectrum with a non-parametric method based on Discrete Fourier
Transform. The ‘‘Bande’’ and ‘‘PiccoBetasigniﬁcativo’’ were used
later to calculate the absolute and normalized power spectrum in
the four bands of interest and to identify, if existing, the value of
the maximum signiﬁcant peak within the beta band and its
frequency.
Pilot user groups were interviewed regarding their early experi-
ence of using the WebBioBank system. The feedback from clini-
cians was positive; the system requires only the completion of a
clinical form. The clinicians were also involved into the deﬁnition
of a unique protocol dedicated to the DBS patients. Also the
researchers were positive about the large amount of data collected
Table 2
Data collected over 1 year.
Name of the Centre (OU) Number of patients Number of signals Types of signals
Ospedale Maggiore Policlinico 20 101 STN-LFPs and GPi-LFPs
Istituto Nazionale Besta 8 15 STN-LFPs
Istituto Neurologico Mondino 18 40 STN-LFPs
Istituto Ortopedico Galeazzi 12 30 STN-LFPs and PPN-LFPs
Table 3
Functions and algorithms implemented in the WebBioBank.
Name of DLL Description
Rimozione_DC Pre-elaboration of the signal: DC removal, subsampling at 500 Hz and ﬁltering in the band of interest 2–45 Hz, (Band-pass, Finite
Impulse Response – FIR)
Filtraggio_banda_Alfa Filters the signal in the band from 8 to 12 Hz (Band-pass, FIR). To be used after ‘‘Rimozione_DC’’
Filtraggio_banda_Basso_Beta Filters the signal in the band from 13 to 20 Hz (Band-pass, FIR). To be used after ‘‘Rimozione_DC’’
Filtraggio_banda_Alto_Beta Filters the signal in the band from 21 to 30 Hz (Band-pass, FIR). To be used after ‘‘Rimozione_DC’’
Spettro Calculates the power spectrum with non-parametric method based on Discrete Fourier Transform
Bande Calculates the absolute and normalised power spectrum relative to the 4 bands of interest: Low Frequencies, Alfa, Low Beta, and High
Beta. To be used after ‘‘Spettro’’
Analisi1 Pre-elaboration of the signal, calculates the power spectrum and returns the absolute power and normalised bands (Low Frequencies,
Alfa, Low Beta, High Beta)
PiccoBetaSigniﬁcativo Identiﬁes, if it exists, the value of the maximum signiﬁcant peak within the beta band (Low and High Beta) and its frequency. To be used
after ‘‘Spettro’’
BandaBetaSigniﬁcativa Locate the beta band determined to be signiﬁcant around the signiﬁcant peak in the beta band. To be used after ‘‘Spettro’’
102 E. Rossi et al. / Journal of Biomedical Informatics 52 (2014) 92–104in anonymous and uniform mode as well as about the conﬁgura-
tion of dedicated signal processing chain. Table 4 shows the results
of the anonymous survey administered to the investigators (n = 10)
regarding user satisfaction. The interview consisted of 7 questions
scored between 0 and 3: 0 corresponded to ‘‘not at all satisﬁed’’
and 3 to ‘‘very satisﬁed’’. We considered a threshold score of 2 to
consider the judgement as positive. All of the questions obtained
a mean score higher than 2.
4. Discussion
4.1. Main results
We presented the prototype implementation and the ﬁrst use of
WebBioBank, which is a dedicated rEHR – signal processing frame-
work that is able to collect clinical and neurophysiological data
from different research centres while managing multi-centre data
collection.
WebBioBank represents a signiﬁcant advancement for neuro-
physiological research for DBS and PD. First, no databases are spe-
ciﬁcally devoted to LFP recordings from Parkinson’s Disease
patients. Second, this database provides a shared set of analysis
algorithms and processing chains dedicated to DBS LFP, allowing
homogeneous data collection and signal processing. Third, this sys-
tem can manage multi-centre neurophysiological studies towards
elucidating the mechanism of action of DBS using a two-layer user
organisation based on OUs and sOU with speciﬁc user roles. Fourth,
this database is a ﬂexible solution that allows for the deﬁnition ofTable 4
Results of the satisfaction survey.
1. Ease of access to the system
2. User friendly web interface
3. rEHR dedicated to the evaluation of Parkinson’s Disease, and DBS is
the information according to the multi-centre protocol
4. Data input is easy and immediate
5. Connection to the database for the data extraction is easy and imme
6. Clear and simple operative instructions
7. Compliance of the web-based platform conﬁguration with the needs
Scale: 0 = for not at all satisﬁed, 1 = not very satisﬁed, 2 = satisﬁed, 3 = verroles and data access permissions for different users according to
the protocol. Finally, WebBioBank is the ﬁrst system in neurologi-
cal research integrating a framework for clinical form management
with a web-based platform for advanced bio-signal processing that
can be updated by the researchers with new algorithms through
.dll functions. Although it is becoming increasingly outdated, the
.dll format for algorithm upload reﬂects the present practice of
researchers working in biosignal analysis: the preferred work envi-
ronment is Matlab, which allows the developed scripts to be com-
piled as executable ﬁles. The Matlab Compiler Runtime provides
the libraries for running the executable ﬁles. Consequently,
researchers in biomedical signal processing can easily use the sys-
tem without learning any additional languages.
4.2. Limitations and future evolution of the system
This system can meet the speciﬁc needs of multi-centre studies
regarding different pathologies and bio-signals. Using the WebBio-
Bank in the multi-centre study for DBS patients over the last year
has introduced several beneﬁts: a user friendly interface, the col-
lection of large amounts of data in a homogeneous and anonymous
manner and data processing at different levels. However, more
effort should be devoted towards developing the signal processing
module, particularly for classifying the biosignals and of the results
of the elaboration.
Since the WebBioBank was only used for one year, we could not
directly verify to what extent this approach can improve research
regarding DBS mechanism of action. Additional patient enrolmentMean Std
2.6 0.7
2.3 0.7
comprehensive and includes all of 2.6 0.5
2.2 0.8
diate (use of Excel is familiar) 2 0.9
2.1 0.9
of multi-centre protocols 2.5 0.5
y satisﬁed. n = 10.
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statistically relevant results. In particular, we did not set up an
experiment comparing a multi-centre trial run with WebBioBank
with other trials run without it. In our experiment, the researchers
of the centre devoted to signal analysis in a study titled ‘‘Local ﬁeld
potential recordings in Parkinson’s Disease from deep basal ganglia
structures during levodopa and DBS therapy: a multi-centre Italian
study’’ reported that using WebBioBank sped up the process of sig-
nal collection and pooling as well as facilitated signal analysis
because of standardised and pre-deﬁned elaboration chains. Also,
they suggested to improve the connection speed by moving the
service from a local server to a cloud service. These suggestions
relied nevertheless on a small number of investigators (10) and
were sometimes inhomogeneous and require further studies with
more centres to drive deﬁnite conclusions.
The use of WebBioBank is not limited to neurological signals
coming from DBS electrodes. Any biosignal that can be represented
in a bidimensional matrix (time, value) can be processed and
stored within the system, including electroencephalogram electro-
cardiogram, respiratory signals, electromyogram, electrooculo-
gram, and continuous blood pressure monitoring. Each signal can
be represented in WebBioBank and connected to the patient’s
rEHR/CRF, associating it with the appropriate clinical information.
The system is limited by the single-channel inputs, implying that
all of the derivations of a multi-channel signal (e.g., EEG) can be
stored in the repository; their analysis cannot be multi-dimen-
sional. The next release of the system will solve this problem by
allowing multidimensional inputs while maintaining the parent–
child relationship between the raw and analysed signals.
The present experiment did not fully use the semantic interop-
erability functionalities and the deﬁnition and validation of the
dictionary was based on the protocol deﬁned by the four DBS cen-
tres involved. The system, through the Framework Manager, is
however ready to include standard diagnostic terminologies (such
as ICD10) instead of ad-hoc dictionaries and has an annotation
capability (through the ‘‘clinical concepts’’) that was not tested in
this experiment.
Regarding patient privacy, WebBioBank can be improved by
using a client-oriented encryption process. In fact, the present ver-
sion of the system re-identiﬁes the patients based on the re-asso-
ciation of the ID BAC to a corresponding item inside the patient’s
registry (which is an external ﬁle saved locally under the responsi-
bility of the clinician who creates patient’s rEHR). The WebBioBank
Use Policy instructs the user on how to enter personal information
into the system so that the information shared on the platform
does not contain demographic details. During the ﬁrst implemen-
tation of the prototype, the diagnosis code refers to neurological
evaluation scales or to LFP parameters: for the genomics biobanks,
the risk for re-identiﬁcation is lower. To understand whether the
health data were sufﬁciently de-identiﬁed, we used the principles
proposed by Malin et al. [31]. The data type shared onWebBioBank
has a low risk of replicability, availability and distinguishability.
Consequently, the risk of re-identiﬁcation is very low without the
external registry. Therefore, we can consider the data sharing
implemented in WebBioBank during neurological multi-centre
studies as anonymous from the Data Manager point of view. The
user with the role Data Manager can view all data collected in
the database but he has not the possibility to access to the local
registry (.xml ﬁle) necessary to connect demographic data to clin-
ical/research data. In fact on the web-based platform there are not
identifying information stored and neurological parameters cannot
be considered as indirect identiﬁers. Moreover in the database the
IDBAC is the unique identiﬁer of each record and cannot be
removed as commonly done during data anonymization. This
architecture ensures that the role ‘‘Data Manager’’, who has access
to all the data collected for the analysis, cannot access patient’sdemographics in any way, since this information is stored sepa-
rately from research data in the local registry managed by the sin-
gle OU and it is replaced by the unique identiﬁer that creates a new
identity, thus protecting against accidental disclosure outside the
research protocol (Safe Harbor Method according to HIPAA Privacy
Rule at 45 CFR Part 164). On the clinical OU side it is necessary to
maintain the possibility to link the IDBAC with patient’s demo-
graphics in order to allow the clinical user to manage and assess
the patient properly. Data in this case can be considered as de-
identiﬁed. In addition, in Italy, data are considered as anonymized
for research purposes (D.L. n. 179/2012, art. 12, comma 6) if data
do not contain information that can be used to identify the patient,
as: tax number, name and surname, birth date, ID card number,
address, telephone number, email address (or any other digital
account information), scanned copy of documents that include
identiﬁcation information. None of these is included in WebBio-
Bank on the server side and cannot be shared among centres.
Hence, according to the Italian law, WebBioBank treats only anon-
ymized data for research purposes.
To use WebBioBank in different medical research ﬁelds, the pri-
vacy of the patients must be improved using a client-oriented
encryption process to reduce the risk of re-identiﬁcation. The expe-
rience with the i2b2 use cases [32] indicates that the privacy of the
patient should be considered on three fronts: technical de-identiﬁ-
cation of the data, trust in the researcher and the research, and the
security of the underlying technical platforms. These three fronts
are controlled in WebBioBank using the following: re-identiﬁca-
tion risk assessment, Use Policy signed by users and SSL with
128bit key encryption standard guaranteed by the wHospital
framework.
4.3. Comparison with other available systems
The integration between clinical data and information and
research data have been increasingly addressed. Several systems
that are able to share clinical and research data are available to
the research community in addition to others that are able to store,
process, and manage data from multi-centre collections as well as
supporting clinical trials. However, none of these integrate their
neurophysiological signal management and analysis capabilities
with an interoperable EHR conﬁgurable framework that also sup-
ports the creation of CRFs in multi-centre clinical trials. These inte-
grated functions represent the unique features that characterise
WebBioBank compared to other available systems.
Compared to the software developed by Daedalus [20] WebBio-
Bank is dedicated to neurophysiological signals and not to data for
hospitals and research centres. Therefore, it provides dedicated
algorithms and analysis chains that can be uploaded by single
researchers and shared. Moreover, WebBioBank allows for the cre-
ation of CRFs to be shared across centres in multicentre clinical tri-
als through the included interoperable rEHR framework.
Even though both WebBioBank and REDCap [22] include auto-
mated export procedures for seamless data downloads to Excel,
WebBioBank also allows researchers to create personal analysis
functions and to generate signal processing chains dedicated to
each research protocol.
Similarly to i2b2, WebBioBank implements the integration of
neurophysiological signals and clinical characteristics in patients
using a document-oriented message system: within the Signal Pro-
cessing Module, all metadata are exchanged among different anal-
ysis blocks according to the processing chain speciﬁcally developed
for the research protocol. Each analysis block is composed of a .dll
ﬁle uploaded by users that is used to conﬁgure the processing
chain based on the multi-centre study. WebBioBank hence pro-
vides clinical investigators with the software tools necessary to
construct andmanage their research charts in the neurophysiologi-
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messages to manage integration: they can create analysis blocks
just uploading their signal processing algorithms to the web-based
interface in a common .dll format. Another advantage of WebBio-
Bank is the relational schema that speeds up the query process.
When considering systems for shared document management,
like LORIS [5], OnWARD, and SciPort, WebBioBank provides func-
tions for the integration between CRFs and biosignal processing,
can deﬁne different user roles, and allows the OU administrator
to conﬁgure the digital clinical form ﬂexibly according to the data
types needed in a speciﬁc multi-centre study. In addition, the
administrator of each UO and sUO has complete control over a
unique database: through the FrameWork Manager, administra-
tors can conﬁgure the database (tables, views, j-query) according
to the type of data they want to collect and share. Also,
WebBioBank uses a single server that is easily accessible via the
web after authentication to ensure homogeneous data collection
from different centres and integrate signal processing with the
CRFs.
Similar to the Julius system [21], WebBioBank is integrated with
a rEHR system, but Julius does not enable the conﬁguration and
sharing of CRFs according to a multi-centre study protocol, guaran-
teeing uniform data collection into the centralised database. The
Julius system allows integration with the pre-existing local EHR
system. Conversely, WebBioBank includes the rEHR system in a
multi-centre workﬂow.
In conclusion, even though different systems that are devoted to
research ﬁelds other than neurology and neurophysiology provide
capabilities similar to those provided by WebBioBank, none of
them have the same set of functionalities nor do they allow for
the integration of multi-centre clinical data, signal management
and analysis tools with the deﬁnition of CRFs in an interoperable
rEHR environment.
5. Conclusion
The pilot use of WebBioBank in a multi-centre DBS study dem-
onstrates that a user-friendly and anonymous tool for data sharing
that utilises a common research protocol can ensure homogeneous
data collection and immediate inter-centre data comparisons. The
administrator of a Super Operative Unit can conﬁgure the system
by using the experimental protocol, while the Data Manager can
deﬁne signal processing chains dedicated to bio-signal analysis.
These two aspects make WebBioBank a ﬂexible and robust tool
for anonymous data sharing between different multi-centre stud-
ies, which are not limited to neurological research.
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